These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 22030563)

  • 1. NT-proBNP levels in patients with non-ST-segment elevation acute coronary syndrome.
    Castro LR; Alencar MC; Barbosa MM; Nunes Mdo C; Cardoso JR; Ribeiro AL
    Arq Bras Cardiol; 2011 Dec; 97(6):456-61. PubMed ID: 22030563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome.
    Ogawa A; Seino Y; Yamashita T; Ogata K; Takano T
    Circ J; 2006 Nov; 70(11):1372-8. PubMed ID: 17062956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-ProBNP serum levels reflect severity and extent of ischemia in patients admitted with non-ST-elevation acute coronary syndrome.
    Riezebos RK; Ronner E; Tijssen JG; Laarman GJ
    Acute Card Care; 2006; 8(1):51-7. PubMed ID: 16720429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal probrain natriuretic peptide in patients with acute coronary syndrome
.
    Kang Q; Wan Z; Huang Z
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):78-84. PubMed ID: 27879192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].
    Liu WX; Zhao H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
    Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of N-terminal proB-type natriuretic peptide for early identification of myocardial infarction in patients with high-risk non-ST-elevation acute coronary syndromes.
    Riezebos RK; Laarman GJ; Tijssen JGP; Verheugt FWA
    Clin Chem Lab Med; 2011 Aug; 49(8):1359-1365. PubMed ID: 21692686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma S100A1 level is a risk factor for ST-segment elevation myocardial infarction and associated with post-infarction cardiac function.
    Fan L; Liu B; Guo R; Luo J; Li H; Li Z; Xu W
    Int J Med Sci; 2019; 16(8):1171-1179. PubMed ID: 31523180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
    Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of clinical outcome in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) using the TIMI risk score extended by N-terminal pro-brain natriuretic peptide levels.
    Jarai R; Iordanova N; Jarai R; Jarai F; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
    Wien Klin Wochenschr; 2007; 119(21-22):626-32. PubMed ID: 18043882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.
    Dong M; Liao JK; Yan B; Li R; Zhang M; Yu CM
    Int J Cardiol; 2013 Sep; 167(6):2813-9. PubMed ID: 22921817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
    Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
    Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal probrain natriuretic peptide predicts adverse outcomes in acute-myocardial infarction even with preserved left ventricular ejection fraction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2006; 58(2):138-43. PubMed ID: 18989058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
    Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes.
    Zdravkovic V; Mladenovic V; Colic M; Bankovic D; Lazic Z; Petrovic M; Simic I; Knezevic S; Pantovic S; Djukic A; Zdravkovic N
    Kardiol Pol; 2013; 71(5):472-9. PubMed ID: 23788087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes.
    Ndrepepa G; Braun S; Mehilli J; Niemöller K; Schömig A; Kastrati A
    Clin Res Cardiol; 2007 Jan; 96(1):30-7. PubMed ID: 17066344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum NT-proBNP on admission can predict ST-segment resolution in patients with acute myocardial infarction after primary percutaneous coronary intervention.
    Peng B; Xia H; Ni A; Wu G; Jiang X
    Herz; 2015 Sep; 40(6):898-905. PubMed ID: 25997425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.